申请人:Merck Patent GmbH
公开号:US20190322658A1
公开(公告)日:2019-10-24
The present invention provides compounds of Formula I′, or pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods of use thereof for treating cellular proliferative disorders (e.g., cancer).
本发明提供了式I′的化合物,或其药学上可接受的盐,以及用于治疗细胞增殖性疾病(例如癌症)的药物组合物和使用方法。